Exelixis (EXEL) Non-Current Debt (2010 - 2016)

Exelixis' (EXEL) quarterly Non-Current Debt came in at $80.0 million in Q1 2016, little changed year-on-year from $80.0 million in Q2 2015, and little changed quarter-over-quarter from $80.0 million in Q4 2015.

Exelixis (EXEL) Non-Current Debt (2010 - 2016) Analysis & Trends

Exelixis' Non-Current Debt history runs 7 years deep, the most recent figure standing at $80.0 million for Q1 2016.

  • On a quarterly basis, Non-Current Debt changed 0.0% year-over-year to $80.0 million in Q1 2016; TTM through Mar 2016 was $80.0 million, a 0.0% change from a year earlier, with the FY2015 full-year figure at $80.0 million, changed 0.0% from the prior year.
  • Non-Current Debt was little changed at $80.0 million in Q1 2016 per EXEL's latest filing, from $80.0 million in the prior quarter.
  • Across five years, Non-Current Debt topped out at $84.5 million in Q1 2012 and bottomed at $80.0 million in Q3 2014.
  • The 5-year median for Non-Current Debt is $80.2 million (2014), against an average of $81.0 million.
  • Across the five-year window, Non-Current Debt decreased 3.72% in 2012 and changed 0.0% in 2015, its largest moves.
  • Year by year, Non-Current Debt stood at $82.1 million in 2012, then slipped by 2.15% to $80.3 million in 2013, then dropped by 0.41% to $80.0 million in 2014, then changed by 0.0% to $80.0 million in 2015, then changed by 0.0% to $80.0 million in 2016.
  • Per Business Quant, the three latest EXEL Non-Current Debt figures stand at $80.0 million (Q1 2016), $80.0 million (Q4 2015), and $80.0 million (Q3 2015).

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Non-Current Debt (Qtr)
1 Oculis Holding AG 68,785.72 Bn 68,785.72 Bn - -
2 Nanobiotix 1,895.57 Bn 1,895.51 Bn - 105.94 Mn
3 BeOne Medicines 471.35 Bn 466.56 Bn 1.35 Bn 842.92 Mn
4 NuCana 279.75 Bn 279.75 Bn - -
5 Vertex Pharmaceuticals 120.24 Bn 113.00 Bn 2.59 Bn -
6 Regeneron Pharmaceuticals 67.80 Bn 59.04 Bn 3.31 Bn 1.99 Bn
7 Belite Bio 62.51 Bn 62.51 Bn - -
8 Argenx Se 57.38 Bn 57.38 Bn 1.41 Bn -
9 Revolution Medicines 37.78 Bn 37.78 Bn - -
10 Exelixis 14.38 Bn 13.60 Bn 590.86 Mn -

Historic Data

Download Data
DateValue
Mar 31, 2016 80.00 Mn
Dec 31, 2015 80.00 Mn
Sep 30, 2015 80.00 Mn
Jun 30, 2015 80.00 Mn
Mar 31, 2015 80.00 Mn
Dec 31, 2014 80.00 Mn
Sep 30, 2014 80.00 Mn
Jun 30, 2014 80.06 Mn
Mar 31, 2014 80.22 Mn
Dec 31, 2013 80.33 Mn
Sep 30, 2013 80.76 Mn
Jun 30, 2013 81.13 Mn
Mar 31, 2013 81.61 Mn
Dec 31, 2012 82.09 Mn
Sep 30, 2012 82.89 Mn
Jun 30, 2012 83.68 Mn
Mar 31, 2012 84.47 Mn
Dec 31, 2011 85.26 Mn
Sep 30, 2011 85.79 Mn
Jun 30, 2011 86.57 Mn